Nasdaq · Services-Medical Laboratories
Natera, Inc. (NTRA)
Natera's next earnings date, recent SEC filings, insider trades and reported financials, with end-of-day prices. Every number carries its date and source.
Last close
$412.10
−0.06% 1 day+151.8% 52 weeks
As of Sep 28, 2026, end of day (IEX). Not a live quote.
NTRA · one year of daily closes
Sep 25, 2025 to Sep 28, 2026 · end of day · IEX
Closing prices, split-adjusted, from trades on the IEX exchange (published the next trading day). Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Key facts
- 1-day change
- −0.06%
- From $412.35 the session before
- 52-week change
- +151.8%
- Close vs close ~252 sessions earlier
- 52-week range
- $160.10–$412.35
- Lowest and highest closing prices
- Market cap
- $59.4B
- Last close × shares outstanding (SEC)
- Revenue (TTM)
- $2.7B
- 12 months to Jun 30, 2026
- Net income (TTM)
- −$192.3M
- 12 months to Jun 30, 2026
- Diluted EPS (TTM)
- −$1.35
- 12 months to Jun 30, 2026
Financials: trailing twelve months from Natera’s reported US-GAAP figures, SEC EDGAR XBRL company facts, period ended Jun 30, 2026.
Recent SEC filings
- Aug 7, 202610-QQuarterly report for the period ended Jun 30, 2026
- Aug 6, 20268-KCurrent report: Earnings results
- Jul 6, 20268-KCurrent report: Executive or director change
- Jun 16, 20268-KCurrent report: Executive or director change; Shareholder vote results
- Jun 5, 20268-KCurrent report: Executive or director change
- May 8, 202610-QQuarterly report for the period ended Mar 31, 2026
- May 7, 20268-KCurrent report: Earnings results
- Apr 23, 2026DEF 14AProxy statement for a shareholder meeting
Source: SEC EDGAR. Each line is written from the form type and the official 8-K item titles; open the filing for the full text. All NTRA filings on EDGAR
Next earnings
~Nov 5, 2026Estimated
Past results were usually filed after the close
Estimated from past filing dates. Natera hasn't announced this date; Vero projects it from the rhythm of its past SEC filings, so treat it as approximate.
Insider activity (last 90 days)
- Open-market buys
- 0
- filings · 0 shares
- Open-market sales
- 30
- filings · 275,919 shares
Latest 5 of 30 filings shown.
- Sheena JonathanDirector, CO-FOUNDERFiled Sep 25, 2026Sale 18,064at $388.01 avg
- Sheena JonathanDirector, CO-FOUNDERFiled Sep 17, 2026Sale 9,150at $351.49 avg
- Rabinowitz MatthewEXECUTIVE CHAIRMAN, DirectorFiled Sep 16, 2026Sale 102,000at $341.15 avg
- Rabinowitz MatthewEXECUTIVE CHAIRMAN, DirectorFiled Sep 11, 2026Sale 50,000at $327.97 avg
- Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSFiled Sep 3, 2026Sale 18,160at $325.88 avg
Source: SEC EDGAR Form 4, filed in the 90 days to Oct 1, 2026. Counts are filings with at least one open-market purchase (P) or sale (S); grants, option exercises, tax withholding and gifts are left out.
Insider share counts and prices are as reported on Form 4.
With a free Vero account
What Vero tracks about Natera
Each new Natera filing and headline, summarized in plain English and scored 1–10 for how much it matters. Write down why you own NTRA, and Vero reads every new item against those reasons: confirms, challenges or breaks. Alerts say when something crosses the line you set.
Natera (NTRA): questions, answered from the data
When is Natera's next earnings date?
What was NTRA's last closing price?
Have Natera insiders bought or sold shares recently?
What did Natera file with the SEC most recently?
Is this page a recommendation to buy or sell NTRA?
More stock pages
Prices: IEX HIST end-of-day bars, published the next trading day; never live. Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Filings, Form 4 and financials: Source: SEC EDGAR. Earnings dates: Vero’s calendar, marked confirmed or estimated.
Vero is a research tool, not a financial adviser. Nothing on this site is financial advice or a recommendation to buy or sell any security.
Data as of Oct 1, 2026.